Ginkgo Bioworks Holdings Gross Profit 2020-2023 | DNA
Ginkgo Bioworks Holdings gross profit from 2020 to 2023. Gross profit can be defined as the profit a company makes after deducting the variable costs directly associated with making and selling its products or providing its services.
Ginkgo Bioworks Holdings Annual Gross Profit
(Millions of US $) |
| 2022 |
$273 |
| 2021 |
$184 |
| 2020 |
$61 |
| 2019 |
$54 |
Ginkgo Bioworks Holdings Quarterly Gross Profit
(Millions of US $) |
| 2023-03-31 |
$58 |
| 2022-12-31 |
$68 |
| 2022-09-30 |
$42 |
| 2022-06-30 |
$81 |
| 2022-03-31 |
$83 |
| 2021-12-31 |
$82 |
| 2021-09-30 |
$55 |
| 2021-06-30 |
$27 |
| 2021-03-31 |
$20 |
| 2020-12-31 |
|
| 2020-09-30 |
$12 |
| 2019-12-31 |
|
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$3.379B |
$0.478B |
|
Ginkgo Bioworks platform is enabling biotechnology applications across diverse markets, from food and agriculture to industrial chemicals to pharmaceuticals. Ginkgo Bioworks, formerly known as Soaring Eagle Acquisition Corp., is based in NEW YORK.
|
